Improving Data and Analysis to Support National Drug Abuse Policy — Main Report
Jan 1, 1994
|PDF file||9.7 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
The purpose of this report is to provide the Office of National Drug Control Policy (ONDCP) with an analysis of both the problems and untapped potential for existing data to be used more creatively in exploring drug policy issues and to suggest guidelines and a conceptual framework for identifying and evaluating data needs and analyses that will effectively support national substance abuse policy. Rather than continue to "measure what's measurable" we argue that data improvement efforts should explore options to fill major data gaps using alternative systems. We examine disease reporting systems and registries used in public health injury and illness surveillance as models for developing drug policy data on special populations.
This report is part of the RAND Corporation Draft series. The unrestricted draft was a product of the RAND Corporation from 1993 to 2003 that represented preliminary or prepublication versions of other more formal RAND products for distribution to appropriate external audiences. The draft could be considered similar to an academic discussion paper. Although unrestricted drafts had been approved for circulation, they were not usually formally edited or peer reviewed.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.